Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema

• 資料種別: 記事
• タイトル: Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema
• 著者標目: J. Fernando Arevalo; Jans Fromow-Guerra; Hugo Quiroz-Mercado; Juan G. Sanchez; Lihteh Wu; Mauricio Maia; Maria H. Berrocal; Adriana Solis-Vivanco; Michel E. Farah
• 出版年月日等: 2007-04
• 出版年（W3CDTF）: 2007-04
• タイトル（掲載誌）: Ophthalmology
• 巻号年月日等（掲載誌）: 114 4
• 掲載巻: 114
• 掲載号: 4
• 掲載ページ: 743-750
• 掲載年月日（W3CDTF）: 2007-04
• ISSN（掲載誌）: 01616420
• 出版事項（掲載誌）: Elsevier BV
• 対象利用者: 一般
• DOI: 10.1016/j.ophtha.2006.12.028
• 作成日（W3CDTF）: 2007-03-31
• 著作権情報: https://www.elsevier.com/tdm/userlicense/1.0/
• 関連情報（URI）: https://api.elsevier.com/content/article/PII:S0161642007000188?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0161642007000188?httpAccept=text/plain
• 参照: Indocyanine Green Angiography-Guided Focal Laser Photocoagulation for Diabetic Macular Edema; https://cir.nii.ac.jp/crid/1360004236406370560; Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with “Treat-and-Extend” Regimen—Its Usefulness and Problems; https://cir.nii.ac.jp/crid/1360009142834036608; Progress of Diabetic Macular Edema after Loading Injection of Anti-Vascular Endothelial Growth Factor Agents in Real-World Cases; https://cir.nii.ac.jp/crid/1360298757455057280; Effects of kallidinogenase in patients undergoing vitrectomy for diabetic macular edema; https://cir.nii.ac.jp/crid/1360567181320119424; The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits; https://cir.nii.ac.jp/crid/1360567182095844352; Aqueous cytokine and growth factor levels indicate response to ranibizumab for diabetic macular oedema; https://cir.nii.ac.jp/crid/1360567185999419264; Response to Initial Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema Is Significantly Correlated with Response to Third Consecutive Monthly Injection; https://cir.nii.ac.jp/crid/1360580232191973120; Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes; https://cir.nii.ac.jp/crid/1360848656163188736; Two year result of intravitreal bevacizumab for diabetic macular edema using treat and extend protocol; https://cir.nii.ac.jp/crid/1362825893291801088; CLINICAL INVESTIGATION : Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema; https://cir.nii.ac.jp/crid/1520291855780964352; Clinical investigation: Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion; https://cir.nii.ac.jp/crid/1521699228435570176; CLINICAL INVESTIGATION : Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy; https://cir.nii.ac.jp/crid/1524232504640362112
• 連携機関・データベース: 国立情報学研究所 : CiNii Research
• 提供元機関・データベース: Crossref; https://www.crossref.org; CiNii Articles
• NII論文ID: 30026853703